1	In	in	_	_	_	_	_	_	_
2	vivo	vivo	_	_	_	_	_	_	_
3	modulation	modulation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
6	receptor	receptor	_	_	_	_	_	_	_
7	mRNA	mrna	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	inhaled	inhale	_	_	_	_	_	_	_
10	fluticasone	fluticasone	_	_	_	_	_	_	_
11	propionate	propionate	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	bronchial	bronchial	_	_	_	_	_	_	_
14	mucosa	mucosa	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	blood	blood	_	_	_	_	_	_	_
17	lymphocytes	lymphocyte	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	subjects	subject	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	mild	mild	_	_	_	_	_	_	_
22	asthma	asthma	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	BACKGROUND	background	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	In	in	_	_	_	_	_	_	_
4	vivo	vivo	_	_	_	_	_	_	_
5	regulation	regulation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
9	receptor	receptor	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	GR	GR	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
15	provides	provide	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	means	means	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	modulating	modulate	_	_	_	_	_	_	_
20	sensitivity	sensitivity	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	targeted	target	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	OBJECTIVE	objective	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	We	we	_	_	_	_	_	_	_
4	sought	seek	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	determine	determine	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	vivo	vivo	_	_	_	_	_	_	_
10	modulation	modulation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	GR	GR	_	_	_	_	_	_	_
13	mRNA	mrna	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	fluticasone	fluticasone	_	_	_	_	_	_	_
17	propionate	propionate	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	FP	FP	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	subjects	subject	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	mild	mild	_	_	_	_	_	_	_
25	asthma	asthma	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Ten	ten	_	_	_	_	_	_	_
4	atopic	atopic	_	_	_	_	_	_	_
5	asthmatic	asthmatic	_	_	_	_	_	_	_
6	subjects	subject	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	treated	treat	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	FP	FP	_	_	_	_	_	_	_
11	250	250	_	_	_	_	_	_	_
12	microg	microg	_	_	_	_	_	_	_
13	twice	twice	_	_	_	_	_	_	_
14	daily	daily	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	4	4	_	_	_	_	_	_	_
17	weeks	week	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Before	before	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	after	after	_	_	_	_	_	_	_
4	treatment	treatment	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	patients	patient	_	_	_	_	_	_	_
8	underwent	undergo	_	_	_	_	_	_	_
9	fiberoptic	fiberoptic	_	_	_	_	_	_	_
10	bronchoscopy	bronchoscopy	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	endobronchial	endobronchial	_	_	_	_	_	_	_
13	biopsy	biopsy	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	sampling	sampling	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	venous	venous	_	_	_	_	_	_	_
18	blood	blood	_	_	_	_	_	_	_
19	for	for	_	_	_	_	_	_	_
20	measurements	measurement	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	GR	GR	_	_	_	_	_	_	_
23	mRNA	mrna	_	_	_	_	_	_	_
24	levels	level	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	solution	solution	_	_	_	_	_	_	_
3	hybridization	hybridization	_	_	_	_	_	_	_
4	assay	assay	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	used	use	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	quantitative	quantitative	_	_	_	_	_	_	_
9	analysis	analysis	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	GR	GR	_	_	_	_	_	_	_
12	mRNA	mRNA	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	24-hour	24-hour	_	_	_	_	_	_	_
6	urinary	urinary	_	_	_	_	_	_	_
7	cortisol	cortisol	_	_	_	_	_	_	_
8	excretion	excretion	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	an	an	_	_	_	_	_	_	_
11	adrenocorticotropic	adrenocorticotropic	_	_	_	_	_	_	_
12	hormone	hormone	_	_	_	_	_	_	_
13	test	test	_	_	_	_	_	_	_
14	before	before	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	after	after	_	_	_	_	_	_	_
17	treatment	treatment	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	FP	FP	_	_	_	_	_	_	_
20	were	be	_	_	_	_	_	_	_
21	performed	perform	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	A	a	_	_	_	_	_	_	_
4	high	high	_	_	_	_	_	_	_
5	interindividual	interindividual	_	_	_	_	_	_	_
6	variation	variation	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	GR	GR	_	_	_	_	_	_	_
9	mRNA	mRNA	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	seen	see	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	detected	detect	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	significant	significant	_	_	_	_	_	_	_
7	reduction	reduction	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	GR	GR	_	_	_	_	_	_	_
11	mRNA	mrna	_	_	_	_	_	_	_
12	levels	level	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	endobronchial	endobronchial	_	_	_	_	_	_	_
16	biopsy	biopsy	_	_	_	_	_	_	_
17	specimens	specimen	_	_	_	_	_	_	_
18	after	after	_	_	_	_	_	_	_
19	FP	FP	_	_	_	_	_	_	_
20	treatment	treatment	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	36.6	36.6	_	_	_	_	_	_	_
23	+/-	+/-	_	_	_	_	_	_	_
24	23.1	23.1	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	25.0	25.0	_	_	_	_	_	_	_
27	+/-	+/-	_	_	_	_	_	_	_
28	10.9	10.9	_	_	_	_	_	_	_
29	amol	amol	_	_	_	_	_	_	_
30	GR	gr	_	_	_	_	_	_	_
31	mRNA/microg	mrna/microg	_	_	_	_	_	_	_
32	RNA	RNA	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	respectively	respectively	_	_	_	_	_	_	_
35	;	;	_	_	_	_	_	_	_
36	P	p	_	_	_	_	_	_	_
37	<.01	<.01	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	peripheral	peripheral	_	_	_	_	_	_	_
4	blood	blood	_	_	_	_	_	_	_
5	lymphocytes	lymphocyte	_	_	_	_	_	_	_
6	an	an	_	_	_	_	_	_	_
7	even	even	_	_	_	_	_	_	_
8	more	more	_	_	_	_	_	_	_
9	striking	striking	_	_	_	_	_	_	_
10	downregulation	downregulation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	GR	gr	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	its	its	_	_	_	_	_	_	_
16	cognate	cognate	_	_	_	_	_	_	_
17	ligand	ligand	_	_	_	_	_	_	_
18	was	be	_	_	_	_	_	_	_
19	documented	document	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	30.3	30.3	_	_	_	_	_	_	_
22	+/-	+/-	_	_	_	_	_	_	_
23	26.5	26.5	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	8.8	8.8	_	_	_	_	_	_	_
26	+/-	+/-	_	_	_	_	_	_	_
27	5	5	_	_	_	_	_	_	_
28	amol	amol	_	_	_	_	_	_	_
29	GR	gr	_	_	_	_	_	_	_
30	mRNA/microg	mrna/microg	_	_	_	_	_	_	_
31	RNA	RNA	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	respectively	respectively	_	_	_	_	_	_	_
34	;	;	_	_	_	_	_	_	_
35	P	p	_	_	_	_	_	_	_
36	<.001	<.001	_	_	_	_	_	_	_
37	)	)	_	_	_	_	_	_	_
38	,	,	_	_	_	_	_	_	_
39	possibly	possibly	_	_	_	_	_	_	_
40	reflecting	reflect	_	_	_	_	_	_	_
41	differences	difference	_	_	_	_	_	_	_
42	in	in	_	_	_	_	_	_	_
43	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
44	sensitivity	sensitivity	_	_	_	_	_	_	_
45	between	between	_	_	_	_	_	_	_
46	tissues	tissue	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	small	small	_	_	_	_	_	_	_
3	but	but	_	_	_	_	_	_	_
4	significant	significant	_	_	_	_	_	_	_
5	reduction	reduction	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	24-hour	24-hour	_	_	_	_	_	_	_
9	urinary	urinary	_	_	_	_	_	_	_
10	cortisol	cortisol	_	_	_	_	_	_	_
11	excretion	excretion	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	observed	observe	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	233	233	_	_	_	_	_	_	_
16	+/-	+/-	_	_	_	_	_	_	_
17	109	109	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	157	157	_	_	_	_	_	_	_
20	+/-	+/-	_	_	_	_	_	_	_
21	66	66	_	_	_	_	_	_	_
22	nmol/L	nmol/l	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	respectively	respectively	_	_	_	_	_	_	_
25	;	;	_	_	_	_	_	_	_
26	P	p	_	_	_	_	_	_	_
27	<.01	<.01	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	whereas	whereas	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	feedback	feedback	_	_	_	_	_	_	_
33	regulation	regulation	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
36	synthesis	synthesis	_	_	_	_	_	_	_
37	by	by	_	_	_	_	_	_	_
38	means	mean	_	_	_	_	_	_	_
39	of	of	_	_	_	_	_	_	_
40	the	the	_	_	_	_	_	_	_
41	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	_	_	_	_	_	_	_
42	axis	axis	_	_	_	_	_	_	_
43	as	as	_	_	_	_	_	_	_
44	assessed	assess	_	_	_	_	_	_	_
45	by	by	_	_	_	_	_	_	_
46	the	the	_	_	_	_	_	_	_
47	adrenocorticotropic	adrenocorticotropic	_	_	_	_	_	_	_
48	hormone	hormone	_	_	_	_	_	_	_
49	test	test	_	_	_	_	_	_	_
50	remained	remain	_	_	_	_	_	_	_
51	normal	normal	_	_	_	_	_	_	_
52	after	after	_	_	_	_	_	_	_
53	treatment	treatment	_	_	_	_	_	_	_
54	with	with	_	_	_	_	_	_	_
55	FP	FP	_	_	_	_	_	_	_
56	.	.	_	_	_	_	_	_	_

1	CONCLUSION	conclusion	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	The	the	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	this	this	_	_	_	_	_	_	_
7	study	study	_	_	_	_	_	_	_
8	confirm	confirm	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	potency	potency	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	inhaled	inhale	_	_	_	_	_	_	_
14	corticosteroid	corticosteroid	_	_	_	_	_	_	_
15	FP	FP	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	provide	provide	_	_	_	_	_	_	_
18	evidence	evidence	_	_	_	_	_	_	_
19	for	for	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	considerable	considerable	_	_	_	_	_	_	_
22	tissue-specific	tissue-specific	_	_	_	_	_	_	_
23	interindividual	interindividual	_	_	_	_	_	_	_
24	variation	variation	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	expression	expression	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	GR	gr	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

